Nexalis Therapeutics Limited · ASX:NX1
Nexalis Therapeutics — Shareholder Meeting (January 2026)
11 slides from Nexalis Therapeutics's shareholder meeting presentation, Jan 29, 2026
Slide 1: General Meeting
GENERAL MEETING 4.00pm AEDT, Thursday 29 January 2026
Slide 2: Welcome and Agenda
WELCOME AND AGENDA Online attendees • If you have an IT-related issue, please click on the “Raise Hand” button • If there is a question relating to the resolution, shareholders can ask questions by clicking on the Q&A button and typing in your question Agenda • Resolutions 1 - 8 • Poll on the resolu
Slide 3: Resolution 1
RESOLUTION 1 To consider and, if thought fit, to pass with or without amendment, the following Resolution as an ordinary resolution: “That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 4,499,914 Shares at $0.033 per Share on the terms and cond
Slide 4: Resolution 2
RESOLUTION 2 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 17,100,000 Placement Shares subscribed for and issued to th
Slide 5: Resolution 3
RESOLUTION 3 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 8,550,000 Placement Options subscribed for by the
Slide 6: Resolution 4
RESOLUTION 4 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 4,600,000 Placement Shares and 2,300,000 Placemen
Slide 7: Resolution 5
RESOLUTION 5 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for the Company to issue up to 1,400,000 Placement Shares and 700,000 Pl
Slide 8: Resolution 6
RESOLUTION 6 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 6,000,000 Placement Options to Peak Asset Managem
Slide 9: Resolution 7
RESOLUTION 7 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as an ordinary resolution: “That, for the purposes of Listing Rule 7.1 and all other purposes, approval is given for the Company to issue 10,892,534 Options to Linlithgow Family Office Pty Lt
Slide 10: Resolution 8
RESOLUTION 8 To consider and, if thought fit, to pass with or without an amendment, the following Resolution as a special resolution: “That, for the purposes of section 157(1)(a) of the Corporations Act and for all other purposes, approval is given for the name of the Company to be changed to Nexali
Slide 11: Poll Meeting Formally Closed
POLL Poll opened by the Chair • Click on “For”, “Against” or “Abstain” on Resolutions 1 - 8 • Shareholders and visitors who are not voting, click “Skip Poll” Poll closed by the Chair Results will be released on ASX shortly after conclusion of the Meeting MEETING FORMALLY CLOSED General Meeting – 29
Nexalis Therapeutics — Shareholder Meeting (January 2026) on 6ix